SEC Form 4/A · accession 0001062993-15-003498
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jennifer M Chao
Director
Period of report
Apr 22, 2015
Accepted (ET)
Jun 22, 2015 · 2:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $37.64 | Apr 22, 2015 | A | 15,000 | A | — | Apr 22, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The purpose of this Form 4/A is solely to correct the exercise price of derivative securities granted to the reporting person and does not represent any acquisition or disposition of shares by the reporting person.
- F2The options were granted on April 22, 2015 and will vest in four equal annual installments beginning on the first anniversary of the grant date.